Clinical Trials Directory

Trials / Completed

CompletedNCT00654134

Inhalation of 20,000 Endotoxin Units(EU) of Clinical Center Reference Endotoxin in Healthy Volunteers

Inhalation of 20,000 EU of Clinical Center Reference Endotoxin in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the inflammatory response to 20,000 endotoxin units (EU) of CCRE (Clinical Center Reference Endotoxin) inhalation in a cohort of healthy volunteers. Preferably these subjects will have participated in ozone exposure studies, allowing a direct comparison of their responses to both endotoxin and ozone. Additionally, cardiovascular endpoints will be investigated with the CCRE exposure.

Conditions

Interventions

TypeNameDescription
BIOLOGICALClinical Center Reference Endotoxin20,000 EU inhaled

Timeline

Start date
2005-10-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2008-04-07
Last updated
2013-08-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00654134. Inclusion in this directory is not an endorsement.

Inhalation of 20,000 Endotoxin Units(EU) of Clinical Center Reference Endotoxin in Healthy Volunteers (NCT00654134) · Clinical Trials Directory